-
1 Comment
Shaanxi Kanghui Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 0.9% above its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Shaanxi Kanghui Pharmaceutical Co., Ltd's total revenue sank by 2.3% to $116M since the same quarter in the previous year.
Its net income has increased by 1.3% to $13M since the same quarter in the previous year.
Finally, its free cash flow fell by 201.7% to $-38M since the same quarter in the previous year.
Based on the above factors, Shaanxi Kanghui Pharmaceutical Co., Ltd gets an overall score of 3/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE100002XT3 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| Beta | 0.21 |
|---|---|
| PE Ratio | None |
| Target Price | 20.05 |
| Market Cap | 2B |
| Dividend Yield | None |
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 2009 and is based in Xianyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603139.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
